Category

China

China: Tencent, Evergrande, Huitongda, Modern Dental Group, Cosco Shipping Energy Transportation Co. Ltd. (H) and more

By | China, Daily Briefs

In today’s briefing:

  • Tencent Holdings – Bad News On The Doorstep
  • China Evergrande Group – Be A Hero, Take It To Zero
  • Huitongda IPO – First Day Trading
  • Modern Dental Group (3600.HK) – More Suitable for Short Term Trading than Long Term Holding
  • COSCO Shipping Energy (1138 HK): US Crude Export and China Import the Wild Cards?

Tencent Holdings – Bad News On The Doorstep

By Thomas J. Monaco

  • The US Trade Representative (“USTR”) office added Tencent and Alibaba Group to the US government’s latest “notorious markets” list; 
  • Similar to being implicated in running afoul of regulators in mainland China, Tencent “strongly disagrees” with the USTR label; and
  • *We look forward to Tencent’s 4Q21 results announcement on March 23, 2021 where management will continue to refuse to discuss anything meaningful.

China Evergrande Group – Be A Hero, Take It To Zero

By Thomas J. Monaco

  • The shares of Evergrande aren’t worth the paper their printed on;  
  • Shanghai Construction receives a positive court outcome at expense of Evergrande; and
  • The likelihood that Evergrande has enough liquidity and will not have a fire sale of assets is nil – we can add Evergrande to the list of the walking dead. 

Huitongda IPO – First Day Trading

By Oshadhi Kumarasiri

  • Huitongda (9878 HK) had a subdued stock market debut with shares opening marginally above the IPO price.
  • Its subdued first-day performance suggests that investors are no longer misled by artificially low valuation multiples of “1P” EC players.
  • Based on EV/ (GMV + Retail Revenue), there’s a 38% downside to Huitongda’s valuation. However, it may be best to wait for signs of weakness before arranging a short position.

Modern Dental Group (3600.HK) – More Suitable for Short Term Trading than Long Term Holding

By Xinyao (Criss) Wang

  • The impact of dental implants centralized procurement on Modern Dental Group (3600 HK) (MDG) could be limited, and the strategic partnership with Meitu Inc (1357 HK) on “QJ Smile” also brings more possibilities.
  • The concerns include doubts on R&D/innovation capability, complex international relations, foreign policy disturbances, unsettling macro environment and immature invisible orthodontic business, bringing uncertainties in terms of future development outlook.
  • Although the 2021 full-year performance is worth looking forward to, which could be the short-term catalyst, MDG is more suitable for short term trading than long term holding.

COSCO Shipping Energy (1138 HK): US Crude Export and China Import the Wild Cards?

By Osbert Tang, CFA

  • US crude export growth is the positive driver while China import contraction is the negative for tanker ton-mile demand in last year which contraction 5.3% YoY.  
  • Significant room exists for a rebound in US oil export as oil majors announced plans to increase output. China’s import growth will recover in the next 12-18 months as well. 
  • US oil export to China needs 2x more VLCC than from Arabian Gulf. This bodes well for tanker rate, benefiting Cosco Shipping Energy (1138 HK) in the medium term.

Before it’s here, it’s on Smartkarma

China: Orient Overseas International, Nongfu Spring, Life Insurance Corp of India, Meituan and more

By | China, Daily Briefs

In today’s briefing:

  • HSCI Index Rebalance: 29 Adds, 12 Deletes & Changes to Stock Connect
  • Index Rebalance & ETF Flow Recap: HSI, HSCEI, HSTECH, HSCI, S&P/ASX, SET50, LIC, SBI Sumishin, Crown
  • ECM Weekly (20th Feb 2022) – LIC, SBI Sumishin, Huitongda, Delhivery, Vedant, Persol, Emcure, Linom
  • Meituan Short Gains Reward

HSCI Index Rebalance: 29 Adds, 12 Deletes & Changes to Stock Connect

By Brian Freitas

  • There are 29 inclusions and 12 deletions for the HSCI at the March rebalance. 26 of the inclusions will be added to Connect while all deletes will leave Stock Connect.
  • Some of the Stock Connect deletions have a lot of mainland holdings and there could unwinding of some of the positions ahead of becoming sell-only on the link.
  • Orient Overseas International, United Energy, Cloud Village and Gcl Poly Energy Holdings Limited could also move higher over the next couple of weeks before the stocks enter Stock Connect.

Index Rebalance & ETF Flow Recap: HSI, HSCEI, HSTECH, HSCI, S&P/ASX, SET50, LIC, SBI Sumishin, Crown

By Brian Freitas

  • Hang Seng announced the results of the March rebalance post market close Friday. Two adds for the HSI, one set of changes for HSCEI, three sets for HSTECH.
  • An ad hoc rebalance was announced for the KOSDAQ150 following Osstem being designated an ‘Administrative Issue’. In IPO world, we have LIC in India and SBI Sumishin NetBank coming up.
  • Friday was the review cutoff date for the March rebalance of the ASX200 Index. The ATO has provided Aventus with the tax ruling and that creates a timing issue.

ECM Weekly (20th Feb 2022) – LIC, SBI Sumishin, Huitongda, Delhivery, Vedant, Persol, Emcure, Linom

By Sumeet Singh


Meituan Short Gains Reward

By Thomas Schroeder

  • Meituan short near 300 and on the  bear wedge break has paid off. Friday’s price action is disturbing and warrants a downgrade.
  • The breakdown below flat range/triangle support is a big negative on the back of sell volume. Bear triangle breaks are often volatile affairs.
  • 142 is the fresh downside projection. 200 represents the sell barrier to work with.

Before it’s here, it’s on Smartkarma

China: Nongfu Spring, Xinyi Solar Holdings, Asia High Yield Bond Index, Agile Property Holdings, Huize Holding Limited, HKEX, SenseTime Group and more

By | China, Daily Briefs

In today’s briefing:

  • HSI Index Rebalance: Nongfu Spring & Lenovo IN; Still Tiptoeing Towards 80 Index Members
  • HSCEI Index Rebalance: Another Evergrande Stock Is Deleted; Xinyi Solar IN
  • Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers
  • Chinese Property Weekly – Lucror Analytics
  • Huize: Getting More Difficult to Justify an Investment
  • HKEx (388.HK): Latest COVID Outbreak Weighted Trading Activities
  • Hang Seng TECH Index Rebalance: Forced Changes Lead to BIG Turnover

HSI Index Rebalance: Nongfu Spring & Lenovo IN; Still Tiptoeing Towards 80 Index Members

By Brian Freitas

  • The Hang Seng Index was meant to have 80 constituents by mid-2022 before moving to 100 members. At 66 constituents post the March review, we are not gonna make it.
  • Nongfu Spring (9633 HK) and Lenovo (992 HK) will be added to the index. Nongfu’s inclusion was expected while Lenovo is a relative surprise.
  • Nongfu Spring (9633 HK) will also be added to the FTSE AW Index at the March SAIR at the close on 18 March. The stock should move higher.

HSCEI Index Rebalance: Another Evergrande Stock Is Deleted; Xinyi Solar IN

By Brian Freitas


Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

By BondEvalue

S&P and Nasdaq dropped sharply again on Thursday as Russia-Ukraine risk-off sentiment hit markets – the indices were down 2.1% and 2.9% respectively. Most sectors were in the red, led by IT, Communication Services and Consumer Discretionary, down over 2.5% each. The US 10Y Treasury yield was down 4bp at 1.99%. European markets were lower with the DAX, CAC and FTSE down 0.7%, 0.3% and 0.9% each. Brazil’s Bovespa closed 1.4% higher. In the Middle East, UAE’s ADX was up 0.1% and Saudi TASI closed 0.2% lower. Asian markets have opened broadly higher with Shanghai, HSI and STI up 0.4%, 0.3% and 0.4% respectively, while Nikkei was down 0.2%. US IG CDS spreads were 2.5bp wider and HY CDS spreads were 10.5bp wider. EU Main CDS spreads were 1.5bp wider and Crossover CDS spreads were 7.7bp wider. Asia ex-Japan CDS spreads were 1.2bp wider.

Chinese Property Weekly – Lucror Analytics

By Charles Macgregor

The Chinese Property Weekly focuses on providing updates in the Chinese real-estate sector, including recent regulatory and company developments, top and bottom performers, rating actions, as well as a list of bond maturities in the next 30 days.


Huize: Getting More Difficult to Justify an Investment

By Alec Tseung

  • Huize’s further acceleration of the “online to offline integration strategy” likely pushes it to compete more directly against China’s insurance giants (e.g., Ping An).
  • One key challenge smaller Chinese insurtech players face (when it comes to attracting investors) is that some of the country’s insurance giants are relatively well digitized.
  • Ping An still represents a good way to gain exposure to China’s broader insurance/insurtech space, especially given its current low valuation. 

HKEx (388.HK): Latest COVID Outbreak Weighted Trading Activities

By Roger Xie

  • The sluggish share performance of HKEX (388 HK) underscored the weak trading activities at Hong Kong, its January average daily turnover (ADT) is down 47% year-over-year.
  • Hong Kong’s surging COVID cases have already accounted for more confirmed infections than all previous outbreak combined, we believe this will also dampen market sentiment short-term.
  • However, we remain bullish on HKEX (388 HK) with the view that China economy will likely rebound in 2022, which will drive the rebound of IPO activities and trading volume. 

Hang Seng TECH Index Rebalance: Forced Changes Lead to BIG Turnover

By Brian Freitas


Before it’s here, it’s on Smartkarma

China: Tomson, Huitongda, CATL (A), China Southern Airlines, Asia High Yield Bond Index, ABM Investama and more

By | China, Daily Briefs

In today’s briefing:

  • Tomson Group (258 HK): The Next Rivera
  • Huitongda (汇通达) IPO Trading – Subscription Rates and Cornerstone Quality Leaves Much to Be Desired
  • CATL Considers Building More Factories Outside China, Including U.S.
  • China Southern Airlines (1055 HK): A Tough Start
  • BOC HK Launches $ Bond; Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers
  • Asia HY Trade Book – February 2022 – Lucror Analytics

Tomson Group (258 HK): The Next Rivera

By David Blennerhassett

  • At 0.3x price to book, PRC property play Tomson (258 HK) is cheap. 
  • It is even cheaper when factoring in its net cash worth 90% of the market cap.
  • And it might continue to trade cheaply if not for the fact the controlling family recently privatised a connected company of Tomson’s.

Huitongda (汇通达) IPO Trading – Subscription Rates and Cornerstone Quality Leaves Much to Be Desired

By Clarence Chu

  • Huitongda (9878 HK) raised around US$285m in its Hong Kong IPO.
  • Overall, we are not comfortable with paying a premium valuation for HTD given its small scale of operations in a highly competitive and fragmented market. 
  • In this note, we will look at the trading dynamics and current valuation.

CATL Considers Building More Factories Outside China, Including U.S.

By Caixin Global

  • The world’s largest electric-vehicle battery maker Contemporary Amperex Technology Co. Ltd. (CATL) has announced that it’s considering building more factories overseas
  • The news came as CATL (300750.SZ +0.72%), based in East China’s Fujian province, has been trying to ease investor concerns about the recent sell-off of its stock
  • The statement also disclosed that the company has been talking with U.S. clients about the possibility of building production lines in the country to bring supplies of CATL products closer to home

China Southern Airlines (1055 HK): A Tough Start

By Osbert Tang, CFA

  • While China Southern Airlines (1055 HK) saw passenger traffic up 17.3% in Jan, this is at the expense of higher capacity, leading to a 1.8pp YoY passenger load contraction. 
  • Its cargo traffic underperformed both CEA and Air China with a YoY decline; and this is disappointing in a period of time where airfreight rate is at record-breaking level.  
  • We see reduced local travel demand, higher operating costs, weaker cargo business, pressure on yield and higher base of comparison key challenges in 2022, and prefer Air China Ltd (753 HK). 

BOC HK Launches $ Bond; Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

By BondEvalue

S&P and Nasdaq were near flat on Wednesday, after rallying up 1.6% and 2.5% on Tuesday. Most sectors were in the green, led by Energy and Materials and Industrials, up over 0.5% each. The US 10Y Treasury yield was flat at 2.03%. European markets were marginally lower with the DAX, CAC and FTSE down 0.3%, 0.2% and 0.1% each. Brazil’s Bovespa closed 0.3% higher. In the Middle East, UAE’s ADX was up 0.3% and Saudi TASI closed 1.2% higher. Asian markets have opened broadly higher with Shanghai, HSI and STI up 0.4%, 0.3% and 0.4% respectively, while Nikkei was down 0.2%. US IG CDS spreads were 0.2bp tighter and HY CDS spreads were 4.9bp tighter. EU Main CDS spreads were 0.05bp wider and Crossover CDS spreads were 0.8bp tighter. Asia ex-Japan CDS spreads were 1.6bp wider.

Asia HY Trade Book – February 2022 – Lucror Analytics

By Charles Macgregor

The Asia HY Trade Book for the month of February includes a summary of our recommendations, as well as our high-conviction ideas. The report also features relative-value charts and lists of the bonds in the Lucror Asia HY index.


Before it’s here, it’s on Smartkarma

China: Alibaba Group, JD Logistics, Bilibili Inc, Asia High Yield Bond Index and more

By | China, Daily Briefs

In today’s briefing:

  • BABA Triple Low or More to Go?
  • JD Logistics (2618 HK) – Asset Light Model Yet to Yield Higher Returns?
  • Bilibili (BILI): Upgrade to Buy for First Time Before 4Q21 Result
  • Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

BABA Triple Low or More to Go?

By Thomas Schroeder

  • BABA’s slide has been in line. Two key directional break points stand out that will drive the intermediate cycle. The current technical reading remains weak.
  • MACD has drifted higher into the neutral zone while price has traded in a bearish flat range setting up a sell. MACD will be coiled for a fresh down leg.
  • Well defined directional break points lies at 135 (trendline and price pivot) and 100 (triple low support).

JD Logistics (2618 HK) – Asset Light Model Yet to Yield Higher Returns?

By Jason Yap, CFA

  • JD Logistics is a logistics distribution service platform that provides logistics solutions in China through its nationwide warehouse and distribution logistics network
  • Unlike its peers, it does not directly invest in warehouse assets but instead leases them from its parent company JD.com, which theoretically confers advantages of an “asset light” strategy
  • JD Logistics has yet to yield such benefits to date, but its upcoming full year 2021 results could help investors determine potential ROA and margin improvement trends

Bilibili (BILI): Upgrade to Buy for First Time Before 4Q21 Result

By Ming Lu

  • BILI’s stock price has plunged significantly over the past year.
  • We believe the revenue growth will be stable in 4Q21.
  • We believe all business lines remains promising except for advertising.

Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

By BondEvalue

S&P and Nasdaq saw a risk-on move, up 1.6% and 2.5%. Sectoral gains were led by IT and Consumer Discretionary, up 2.7% and 2.1% each. The US 10Y Treasury yield rose by 5bp to go back above the 2% mark to 2.03%. European markets were also higher with the DAX, CAC and FTSE up 2%, 1.9% and 1.1% each. Brazil’s Bovespa closed 0.8% higher. In the Middle East, UAE’s ADX was up 0.3% and Saudi TASI closed 1.2% higher. Asian markets have opened broadly higher with Shanghai, HSI, STI and Nikkei up 0.7%, 1.3%, 0.1% and 2.1% respectively. US IG CDS spreads were 1.9bp tighter and HY CDS spreads were 9.5bp tighter. EU Main CDS spreads were 1.8bp tighter and Crossover CDS spreads were 8.8bp tighter. Asia ex-Japan CDS spreads were 2.3bp wider.

Before it’s here, it’s on Smartkarma

China: Alibaba Group, Zhuzhou CRRC Times Electric Co., Ltd., Linmon Media, China Travel International Investment Hong Kong, Biocytogen Pharmaceuticals (Beijing) and more

By | China, Daily Briefs

In today’s briefing:

  • Alibaba (BABA): Overly Impacted, Accumulate Before 3Q22 Result
  • ZZ CRRC Times Electric (3898): Electrification
  • Linmon Media (柠萌影业) Pre-IPO – Consistently Putting up a Good Show
  • China Travel Intl Inv (308 HK): The Fruit Has Ripened?
  • Pre-IPO Biocytogen Pharmaceuticals – The Novel Development Model Offset the Pipeline’s Shortcomings

Alibaba (BABA): Overly Impacted, Accumulate Before 3Q22 Result

By Ming Lu

  • The stock price declined to a very low level before the market fell.
  • The Chinese e-commerce market is still promising despite of the high comparison base last year.
  • We believe the stock has an upside of 68% for March 2023.

ZZ CRRC Times Electric (3898): Electrification

By Henry Soediarko

  • The new product in IGBT for NEV will be the main driver going ahead riding on the growing EV ecosystem in China.
  • The recent sell-off provides a good entry point for new investors. For those who are already invested, it provides an opportunity to add at a better price. 
  • It is a lesser-known NEV name in China that is still trading at a lower valuation compared to the mega-cap names such as CATL and BYD. 

Linmon Media (柠萌影业) Pre-IPO – Consistently Putting up a Good Show

By Clarence Chu

  • Linmon Media (LM HK) is looking to raise about US$300m in its upcoming Hong Kong IPO.
  • Linmon Media (LM) is a content production firm that operates the full value chain of investment, production, distribution, promotion and derivatives licensing of drama series.
  • In this note, we take a look at LM’s business, financials, and share our thoughts on the IPO.

China Travel Intl Inv (308 HK): The Fruit Has Ripened?

By Osbert Tang, CFA

  • Share price of China Travel International Investment Hong Kong (308 HK) (CTII) rallied 23% in last 3 months and 81% from its trough, which has well reflected the FY21 turnaround.
  • Risk-Return profile looks less attractive as its P/B multiple of 0.56x only provides 14% upside to the historical average of 0.63x. In other words, safety margin has diminished. 
  • Macro picture turned against CTII – weaker-than-expected CNY visitors in Shenzhen, escalating Omicron cases in Hong Kong and caution on domestic tourism outlook all point to a more challenging FY22.

Pre-IPO Biocytogen Pharmaceuticals – The Novel Development Model Offset the Pipeline’s Shortcomings

By Xinyao (Criss) Wang

  • The candidates in Biocytogen’s pipeline do not have advantages in development progress and also have to face fierce competition, so continuous large R&D investment in the future would be inevitable.
  • However, the development model of Biocytogen is very novel and special, which could make it a rare target in the market if it is successfully listed.  
  • Therefore, the certainty of Biocytogen’s future growth is expected to improve gradually, and the mid- and long-term investment value would continue to increase due to the high moat.

Before it’s here, it’s on Smartkarma

China: Alibaba Group, China Unicom Hong Kong, GoGoX Holdings, Lepu Biopharma, China Three Gorges Renewables, Asia High Yield Bond Index and more

By | China, Daily Briefs

In today’s briefing:

  • Alibaba (9988 HK/BABA): Possible Softbank Sale and Passive Impact
  • StubWorld: Unicom’s “Hs” Are Cheap
  • GOGOX IPO Initiation: A Less than Perfect Delivery
  • Lepu Biopharma IPO: PHIP Updates
  • China Three Gorges Renewables (600905 CH): Good, and Better Is Coming
  • Allianz’s 3.875% Perp Drops 5 Points After Skipped Call
  • Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

Alibaba (9988 HK/BABA): Possible Softbank Sale and Passive Impact

By Brian Freitas

  • Alibaba Group (9988 HK) has filed a F-6EF Registration Statement to register an additional 1bn ADS. This will most likely be Softbank Group selling part (or all) of the stake.
  • There is a possibility that Softbank Group (9984 JP) is looking to use the stock as collateral for a financing trade and moving their holdings to a more liquid market.
  • If Softbank Group (9984 JP) sells some of their shares, there will be buying from MSCI and FTSE trackers. There will be minimal buying from HSI, HSCEI and HSTECH trackers.

StubWorld: Unicom’s “Hs” Are Cheap

By David Blennerhassett

  • Despite the recent share price gain, China Unicom (762 HK) is inexpensive with respect to parent China United Network (600050 CH) – its pseudo domestic A-share twin – and to peers.
  • Preceding my comments on Unicom, are the current setup/unwind tables for Asia-Pacific Holdcos. 
  • These relationships trade with a minimum liquidity of US$1mn, and a % market capitalisation >20%.

GOGOX IPO Initiation: A Less than Perfect Delivery

By Arun George

  • GoGoX Holdings (GOGO HK) is a major online intra-city logistics platform in Asia. It is pre-marketing an HKEx IPO to raise US$200 million, according to press reports.   
  • The fundamentals are unattractive as intensifying competition is pressuring growth, increasing losses and spurring cash burn.   
  • As the losses and cash burn is expected to persist over the next three years, we would give the IPO a pass. 

Lepu Biopharma IPO: PHIP Updates

By Shifara Samsudeen, ACMA, CGMA

  • Lepu Biopharma (LBP HK) is a biopharmaceutical company focusing on oncology therapeutics. The company has filed for an IPO to list on the Hong Kong Stock Exchange.
  • Lepu has the leading ADC candidate pipeline in China, in terms of number of clinical-stage ADC drug candidates. In our previous insight, we discussed the company’s business, products and outlook.
  • In this follow-up insight, we have highlighted and discussed some of the key new data points from the company’s Post Hearing Information Pack (PHIP).

China Three Gorges Renewables (600905 CH): Good, and Better Is Coming

By Osbert Tang, CFA

  • China Three Gorges Renewables (600905 CH) (CTGR) has an splendid FY21 as it pre-announced result with a range of 46.5-53.1% growth in recurring profit, fuelled by generation and disposal gains. 
  • The first full-year contribution of many projects commissioned in 4Q21, which boosted a 28.4% QoQ surge in power generation, should underpin FY22 earnings – consensus forecast is expecting 41% growth.
  • YTD, CTGR’s share price performed in line with Shanghai Composite Index (-6.1%), but its strong EPS CAGR of 22% for FY21-23 provides room for it to outperformed in medium term. 

Allianz’s 3.875% Perp Drops 5 Points After Skipped Call

By BondEvalue

German insurer Allianz saw its dollar-denominated 3.875% perpetuals  fall about 5 points late on Monday after the 30-day call announcement window closed, indicating that the issuer will not be redeeming the bonds on the first call date of March 7. The fixed-for-life perpetuals (Term of the Day, explained below) fell 4.7 points this week thus far to currently trade at 93.85 cents on the dollar, yielding 4.13%. A senior syndicate banker told IFR, “There is a long, long track record of issuers making a call based on economics in the US dollar fixed-for-life market. This is not the first time this has happened. I’m quite amused, I can only infer from the price move that some people investing in the bond thought it was going to get called at the first call date, but I’m not sure why.” The bonds are now callable at any time and bankers expect the bond to move close to par once the dust settles, IFR reported.

Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

By BondEvalue

US equity markets fell with the S&P and Nasdaq ending 0.4% and 0.6% lower. Sectoral gains were led by Energy, up 1.3% while losses were led by Communication Services, down 2.2%. US 10Y Treasury yields rose 3bp to 1.94%. European markets were higher with the DAX, CAC and FT SE up 0.7%, 0.8% and 0.8%. Brazil’s Bovespa closed 0.2% lower. In the Middle East, UAE’s ADX was up 0.1% and Saudi TASI closed 0.4% higher. Asian markets have opened mixed with HSI and Shanghai down 1.54% and 0.90% while STI and Nikkei are up 0.57% and 0.24% respectively. US IG CDS spreads were 0.4bp wider and HY CDS spreads were 3.1bp wider. EU Main CDS spreads were 1bp wider and Crossover CDS spreads were 7bp wider. Asia ex-Japan CDS spreads were 3.9bp wider also.

Before it’s here, it’s on Smartkarma

China: China Mobile, Smoore International, Anta Sports Products, Huitongda, China Everbright Environment, MicroPort NeuroTech, Shanghai MicroPort MedBot Group, Asia High Yield Bond Index and more

By | China, Daily Briefs

In today’s briefing:

  • China Mobile (941 HK) Buyback Period Starts
  • Smoore (6969 HK): Expanding Market Sizes, Both Domestic and Global
  • Anta (2020 HK) Inventory Analysis – Structural Tailwinds from the Olympics
  • Huitongda IPO – Valuation
  • China Everbright Environment (257 HK): Roaring in the Year of Tiger!
  • MicroPort NeuroTech IPO: Impressive Product Portfolio Offsets Profitability Concerns
  • Shanghai MicroPort MedBot Group (2252.HK) – Optimistic About the Outlook
  • Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

China Mobile (941 HK) Buyback Period Starts

By Travis Lundy

  • China Mobile (941 HK) announced an H-share buyback program which had as its upper limit the purchase of 37% of the H-share CCASS position. 
  • After that, the SOE parent announced a plan to buy RMB shares in Shanghai. 
  • The virtuous cycle of shareholder return starts today. Today is the first day China Mobile can start buying its H-shares. 

Smoore (6969 HK): Expanding Market Sizes, Both Domestic and Global

By Ming Lu

  • The growth rate of the Chinese e-cigarette market bounced up to 73% in 2021 from 7% in 2020. 
  • The global e-cigarette market increased by 23% in 2021, but Smoore is only good at vaping components.
  • We conclude that Smoore has an upside of 86% for year end 2022.

Anta (2020 HK) Inventory Analysis – Structural Tailwinds from the Olympics

By Jason Yap, CFA

  • Anta benefits from strong tailwinds of the two Olympic events and the Chinese government’s support for citizens’ sports engagement
  • Anta’s inventory position has improved relative to H1 2020. However, it remains weaker than pre-pandemic levels in 2019
  • We analyse Anta’s inventory and highlight key factors to watch in its upcoming FY2021 results

Huitongda IPO – Valuation

By Oshadhi Kumarasiri

  • With churn rates as high as 50% and wholesale customers declining by 27.7% in 9M21, we are not particularly interested in Huitongda (9878 HK) over long term.
  • The valuation looks cheap compared to peers on the surface, but when compared after considering Huitongda’s 1P exposure its at a significant premium to peers.
  • Given that the market takes time to pick up similar mispricing situations, we think its advisable to wait and see where Huitongda opens, before arranging a short position.

China Everbright Environment (257 HK): Roaring in the Year of Tiger!

By Osbert Tang, CFA

  • The FY21 result of China Everbright Environment (257 HK) (CEE) should look impressive and we see improvement in cash flow to relieve market concerns on leverage and financial position.  
  • New project addition is solid over the last three months, adding about 5% to operational project portfolio. Strong special purpose bonds issuance in 4Q21 and 2022 will fuel pipeline momentum.
  • Valuations look undemanding at 4.1x PER and 0.65x P/B for FY22F; and by maintaining payout ratio at c.30%, dividend yields are at attractive 6.4% and 7.4% for next 2 years.

MicroPort NeuroTech IPO: Impressive Product Portfolio Offsets Profitability Concerns

By Shifara Samsudeen, ACMA, CGMA

  • MicroPort is the largest Chinese neuro-interventional medical device company and has filed for an IPO on the Hong Kong Stock Exchange. Its Portfolio consists of 30 commercialised products and candidates.
  • Although struggling with margins, the company has an impressive product portfolio with a majority of them having strong competitive advantages.
  • As most of the products are poised for growth, we are largely positive on the company.  

Shanghai MicroPort MedBot Group (2252.HK) – Optimistic About the Outlook

By Xinyao (Criss) Wang

  • Recently, MicroPort MedBot’s Toumai laparoscopic surgical robot has obtained a registration certificate for launching by NMPA, indicating the hope of breaking the monopoly of Da Vinci robots in the market.
  • The strong policy support as well as the medical insurance coverage offer a viable way for the commercialization of surgical robots in China, which is very important. 
  • Although it would take some time to improve the overall market penetration in China, we are still optimistic about the outlook of Shanghai MicroPort MedBot Group (2252 HK).

Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers

By BondEvalue

US equity markets rose with the S&P and Nasdaq ending 0.5% and 1.6% higher. Sectoral gains were led by Consumer Discretionary, up over 3%. US 10Y Treasury yields rose 7bp to 1.90%. European markets were lower with the DAX, CAC and FTSE down 1.8% 0.8% and 0.2%. Brazil’s Bovespa closed 0.5% higher. In the Middle East, UAE’s ADX was up 0.1% and Saudi TASI closed 0.5% higher. Asian markets have opened mixed with HSI and Nikkei down 0.31% and 0.73% while STI and Shanghai are up 0.32% and 1.91% respectively. US IG CDS spreads were 1bp wider and HY CDS spreads were 9.5bp wider. EU Main CDS spreads were 3.1bp wider and Crossover CDS spreads were 14.3bp wider. Asia ex-Japan CDS spreads were 3.2bp wider also.

Before it’s here, it’s on Smartkarma

China: Ping An Insurance Group Co Of China, Shanghai Medicilon Inc and more

By | China, Daily Briefs

In today’s briefing:

  • Ping An A/H: At Parity Now; Position for Premium Expansion
  • STAR50 Index Rebalance Preview (March 2022): Falling Knives

Ping An A/H: At Parity Now; Position for Premium Expansion

By Brian Freitas


STAR50 Index Rebalance Preview (March 2022): Falling Knives

By Brian Freitas

  • The review period ended last week. There will either be 4 or 5 changes to the SSE STAR50 (STAR50 INDEX) depending on the minimum listing history period used.
  • Shanghai Medicilon Inc (688202 CH) is a high probability inclusion while there are 4 high probability deletions, irrespective of the minimum listing history period used.
  • The potential inclusions have continued to drop and have underperformed the potential deletions. The next couple of weeks could see a reversal in that trend.

Before it’s here, it’s on Smartkarma

China: Oriental Watch, Time Interconnect Technology, China Logistics Property Holdings, China Petroleum & Chemical, Asia High Yield Bond Index and more

By | China, Daily Briefs

In today’s briefing:

  • Oriental Watch: Increasing Visibility on H2 2022
  • Time Interconnect (1729 HK): Possible Offer
  • CLPH (1589 HK): Composite Doc Out. Offer Now Open
  • False Breakdowns on Global MSCI Indexes as the US Dollar Weakens; Ideas Within Energy & Financials
  • Macro; Rating Changes; New Issues; Talking Heads; Top Gainers & Losers

Oriental Watch: Increasing Visibility on H2 2022

By Sameer Taneja

  • We have increasing confidence in Oriental Watch (398 HK) paying out a > 74 cent dividend for FY22 ( implied dividend >40 cents for H2 2022, full-year yield 17%). 
  • Current net cash (ex-of dividend payable) is 1.1 bn HKD accounting for >50% of the market capitalization ( 2.1 bn HKD ), providing a significant margin of safety. 
  • Expanding watch premiums for brands like Rolex and Patek Philippe due to tighter supply could result in better margins for the company, increasing upside potential.

Time Interconnect (1729 HK): Possible Offer

By David Blennerhassett

  • Time Interconnect Technology (1729 HK) is currently suspendedpursuant to The Hong Kong Code on Takeovers and Mergers“.
  • Paul Lo, the chairman, recently increased his stake to ~75% of shares out. A large parcel of shares moved into CCASS late last month. 
  • Paul Lo, if he is the Offeror, is unlikely to table an Offer price significantly higher than the last close, given the recent price increase. A take under is possible. 

CLPH (1589 HK): Composite Doc Out. Offer Now Open

By David Blennerhassett

  • China Logistics Property Holdings (1589 HK)‘s Composite Document has now been despatched. The Offer is open for acceptance with a first close on the 25 February.
  • The Offer from JD.com is conditional on 50% acceptances, with 66.4% in the bag.
  • Done deal and trading through terms. The IFA considers the Offer is fair and reasonable. 

False Breakdowns on Global MSCI Indexes as the US Dollar Weakens; Ideas Within Energy & Financials

By Joe Jasper

  • In last week’s Int’l Compass (Jan. 27) we highlighted that the broad global indexes were breaking down, but that we were watching for potential false breakdowns.
  • We are now getting those false breakdowns as major levels have been reclaimed; we view this as a net positive.
  • We continue to see select areas that are attractive (namely cyclical value and defensive Sectors) and we expect markets to remain mixed.

Macro; Rating Changes; New Issues; Talking Heads; Top Gainers & Losers

By BondEvalue

US equity markets dropped sharply with the S&P and Nasdaq ending 2.4% and 3.7% lower. Sectoral losses were led by Communication Services down 6.8%, while IT and Consumer Discretionary were down over 3%. US 10Y Treasury yields rose 7bp to 1.84%. European markets were also lower with the DAX, CAC and FTSE down 1.6% 1.5% and 0.7%. Brazil’s Bovespa closed 0.2% lower. In the Middle East, UAE’s ADX was down 0.1% and Saudi TASI closed 0.4% lower. Asian markets have opened mixed with HSI and STI up 2.4% and 0.2% while Nikkei was down 0.1%. Shanghai remains closed on account of the lunar new year holidays. US IG CDS spreads were 2.6bp wider and HY CDS spreads were 11.2bp wider. US IG CDX spreads are at its widest levels since November 2020 (see the chart below). EU Main CDS spreads were 4.6bp tighter and Crossover CDS spreads were 19.3bp wider. Asia ex-Japan CDS spreads were flat.

Before it’s here, it’s on Smartkarma